Evidence map›Paper›PMID 39042306›Full record

ArticleObesity surgery2024

One-Year Outcomes in a Supervised Program of Swallowable Intragastric Balloon-Analysis of 486 Patients in a High-Volume Bariatric Centre in Malaysia.

Nik Ritza Kosai, Aishath Azna Ali, Ryan Ghita, Guhan Muthkumaran, Ismail Ali, Guo Hou Loo, Firdaus Hayati

Abstract read
PubMed Publisher
In one paragraph

Article in Obesity surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nik Ritza KosaiDepartment of Surgery, Faculty of Medicine, Universiti Kebangsaan Malaysia, 56000, Kuala Lumpur, Cheras, Malaysia.
Aishath Azna AliDepartment of Surgery, Indira Gandhi Memorial Hospital, 20402, Malé, Republic of Maldives.
Ryan GhitaQueen Elizabeth University Hospital, Glasgow, G51 4TF, UK.
Guhan MuthkumaranDepartment of Surgery, Faculty of Medicine, Universiti Kebangsaan Malaysia, 56000, Kuala Lumpur, Cheras, Malaysia.
Ismail AliDepartment of Surgery, Faculty of Medicine, Universiti Kebangsaan Malaysia, 56000, Kuala Lumpur, Cheras, Malaysia.
Guo Hou LooDepartment of Surgery, Faculty of Medicine, Universiti Kebangsaan Malaysia, 56000, Kuala Lumpur, Cheras, Malaysia.
Firdaus HayatiDepartment of Surgery, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, 88450, Kota Kinabalu, Sabah, Malaysia. m_firdaus@ums.edu.my.ORCID 0000-0002-3757-9744

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe swallowable intragastric balloon (IGB) has recently emerged as a popular alternative for weight loss in Malaysia. It can reduce total body weight loss (TBWL) by 6-15%. We aim to observe positive weight loss up to a year after the swallowable IGB is implanted.

methodsA total of 486 consecutive patients with overweight or obesity who underwent swallowable IGB insertion were included in this prospective data collection.

resultsOut of 486 patients, 404 patients (83%) had complete data at the end of 4 and 12 months. Patients included in the study had a starting mean body mass index of 35.3 ± 7.2 kg/m

conclusionMost weight loss is typically observed within the first 4 months following the procedure. However, it is important to note that patients can continue to experience ongoing weight loss for up to 1 year. The swallowable IGB is a safe and effective option for patients seeking weight loss solutions. It offers numerous advantages, especially its non-invasive procedureless nature, which makes it more appealing to individuals considering this treatment.

Indexed as

Gastric BalloonObesity, MorbidWeight LossAdultBariatric SurgeryBody Mass IndexDeglutitionFemaleHospitals, High-VolumeHumansMalaysiaMaleMiddle AgedProspective StudiesTreatment OutcomeBariatric surgeryGastric balloonObesityWeight reduction

Identifiers

PMID39042306

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.